PMV Pharmaceuticals, Inc. (PMVP)

PMV Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-65.1	-68.96	-73.32	-57.85	-34.44	-25.35
Depreciation & Amortization	1.08	0.89	0.65	1.28	0.32	0.39
Share-Based Compensation	12.05	12.38	10.2	5.34	1.93	0.91
Other Operating Activities	-4.86	0.04	-1.29	4.65	-0.55	1.99
Operating Cash Flow	-56.83	-55.66	-63.76	-46.57	-32.74	-22.07
Capital Expenditures	-1.4	-0.96	-7.98	-1.35	-0.15	-0.11
Change in Investments	-72.62	-49.58	6.62	-142.24	28.06	3.34
Investing Cash Flow	-74.02	-50.55	-1.37	-143.58	27.91	3.23
Share Issuance / Repurchase	35.57	35.58	0.96	2.02	223.18	0.1
Other Financing Activities	-	-	-	-	69.79	61.71
Financing Cash Flow	35.57	35.58	0.96	2.02	292.97	61.81
Exchange Rate Effect	0	0.03	0	0	0	0
Net Cash Flow	-95.29	-70.59	-64.17	-188.13	288.14	42.97
Free Cash Flow	-58.23	-56.62	-71.74	-47.92	-32.89	-22.17
Free Cash Flow Per Share	-1.13	-1.18	-1.57	-1.06	-2.29	-7.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).